Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Lantern Pharma’s AI algorithms to assess blood-brain-barrier permeability to boost drug development, says GlobalData

As the pandemic has continued to impact the world, there has been a growing focus on the importance of developing new treatments for a range of diseases, including those affecting the brain. Lantern Pharma, a clinical-stage biopharmaceutical company, has developed artificial intelligence (AI) algorithms that can predict the blood-brain-barrier permeability of any compound. Lantern Pharma’s […]
Read more

Asia to lead global ethylene capacity additions by 2027, says GlobalData

Asia is expected to lead the global ethylene industry capacity additions with a share of 54.8% by 2027, by gaining capacities from new-build and expansion projects between 2023 and 2027, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Ethylene Industry Capacity and Capital Expenditure (CapEx) Forecast by Region and Countries Including […]
Read more

Tibsovo’s EU approval game changer for patients with acute myeloid leukemia and bile duct cancer in Europe, says Globaldata

Servier Pharmaceuticals recently announced the European Commission (EC) approval of Tibsovo (ivosidenib), as a targeted therapy in two difficult-to-treat oncology indications, acute myeloid leukemia (AML) and advanced cholangiocarcinoma. This marks the first IDH1 inhibitor approved in Europe and will be a game changer for patients with AML and cholangiocarcinoma in Europe, as Tibsovo addresses the […]
Read more

Global military fixed-wing aircraft market to reach $110.6 billion in 2033, forecasts GlobalData

Recent developments in the fields of stealth, speed, connectivity, electronic warfare, and communication have led to an increased focus on developing new aircraft capable of operating in a network-centric battlefield. To meet this demand, emerging militaries like India, Turkey, and Indonesia are focusing on indigenization through a variety of means, such as technology transfer agreements, […]
Read more

Immatics’ IMA203 clinical data to boost TCR-T therapy development in solid tumour, says GlobalData

Immunotherapy-focused biotech Immatics recently announced encouraging interim clinical data from one of the three cohorts of its Phase Ib trial evaluating its leading T-cell receptor-based T-cell (TCR-T) therapy candidate, IMA203. The positive data represents considerable progress in the development of adoptive cell therapies (ACTs) for the treatment of solid cancers, says GlobalData, a leading data […]
Read more

Singapore property insurers will remain profitable in 2023 with adequate reinsurance coverage, says GlobalData

The Singapore property insurers are expected to remain profitable in 2023 due to disciplined underwriting, adequate reinsurance coverage, and growing premiums from compulsory fire insurance, says GlobalData, a leading data and analytics company. According to GlobalData, Singapore’s property insurance industry, in terms of gross written premiums, is projected to grow at a compound annual growth […]
Read more

Sea trials of sixth Kalvari-class submarine to boost India’s self-reliance in building maritime capabilities, says GlobalData

Following the news that the sixth submarine of the Kalvari-class has commenced sea trials; Kandlikar Venkatesh, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “The commencement of sea trials for the sixth Kalvari-class submarine marks a significant milestone, as it moves closer to its induction into the Indian Navy. With […]
Read more

Indra’s Lanza-N radars will allow Indian Navy to upgrade sensor suite of main surface combatants, says GlobalData

Following the news that Spain’s Indra and TATA Advanced Systems Limited (TASL) have initiated the installation of the first of the 23 Lanza-N radars for the Indian Navy; Tushar Mangure, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “The Lanza-N radars are expected to augment the Indian Navy’s surveillance and […]
Read more

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US, finds GlobalData

The cost of disease-modifying therapies (DMTs) for multiple sclerosis (MS) patients in the US has increased since 2020, placing an increasing financial strain on patients, their families, and the healthcare system, says GlobalData, a leading data and analytics company. According to GlobalData’s recent ‘Multiple Sclerosis: Seven-Market Drug Forecast and Market Analysis to 2030 – Update’ […]
Read more
1 … 112 113 114 115 116 … 136